News | February 05, 2015

Association will have new executive VP, leaders in advocacy and policy

February 5, 2015 — Three American Society for Radiation Oncology (ASTRO) staff members have been promoted to new positions: Emily Wilson has been named executive vice president; Dave Adler promoted to vice president of advocacy; and Anne Hubbard promoted to director of health policy, as announced by ASTRO’s board of directors and effective immediately.

“Congratulations to Emily, Dave and Anne for their extraordinary achievements during their combined 18-plus years at ASTRO,” said ASTRO Chief Executive Officer Laura I. Thevenot. “Their exemplary leadership and expertise have enabled ASTRO to be nimble and to exceed our goals for numerous projects and initiatives in today’s demanding health care environment. Health policy, quality and advocacy are among the top five priorities identified in our 2014 member survey; Emily, Dave and Anne will meet those priorities exceptionally well and play a critical role in ASTRO’s continued success to strengthen services to our members, to the radiation oncology specialty and to the more than one million cancer patients who receive radiation therapy each year.”

In her new role as executive vice president, Wilson will provide her strategic vision to ASTRO’s board of directors, CEO and staff to ensure continued success across the organization to meet the goals of ASTRO’s Strategic Plan. She will also continue to oversee ASTRO’s Clinical Affairs division that leads safety, quality and policy initiatives that support ASTRO members, including the soon-to-be launched APEx (Accreditation Program for Excellence), and quality efforts including PQRSwizard, Integrating the Healthcare Enterprise-Radiation Oncology (IHE-RO), guidelines, best practices and white papers. Wilson has been with ASTRO since 2005, first as director of government relations.

Now vice president of advocacy, Adler was previously director of government relations and responsible for leading several significant advocacy campaigns protecting radiation oncology Medicare reimbursement, advancing efforts to end abuse of the physician self-referral law in cancer treatment and developing ASTRO’s payment reform action plan. In his new role, he will oversee both ASTRO’s Government Relations and Health Policy departments, which are responsible for ASTRO’s legislative and regulatory advocacy with federal policymakers including the White House, Congress, agencies within the Department of Health and Human Services, such as the Centers for Medicare and Medicaid Services (CMS), the National Institutes of Health (NIH) and the Food and Drug Administration (FDA), as well as the Nuclear Regulatory Commission. Adler also leads ASTRO efforts to collaborate with medical specialty societies, patient advocacy organizations and other healthcare coalitions.

Hubbard, promoted to director of health policy, joined ASTRO in May 2014 as assistant director of health policy. In her role, Hubbard leads ASTRO’s efforts regarding the economics of managing a radiation oncology practice, including the analysis of Medicare and non-Medicare payer reimbursement policy decisions, as well as the development of ASTRO’s payment reform initiative. She serves as ASTRO’s staff advisor to the American Medical Association’s (AMA’s) CPT Editorial Panel and the RVS Update Committee. Additionally, Hubbard represents ASTRO at the Medicare Payment Advisory Commission and the Advisory Panel on Hospital Outpatient Payment meeting; and works closely with the AMA and other medical specialty societies to achieve common goals.

For more information: www.astro.org


Related Content

News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Breast Imaging

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 14, 2024 — Accuray Incorporated announced that the team at Quebec’s Montérégie Integrated Cancer Center, part ...

Time February 14, 2024
arrow
News | Radiation Oncology

February 12, 2024 — Radformation, a global pioneer in radiation oncology software solutions, is pleased to announce its ...

Time February 12, 2024
arrow
Subscribe Now